Request Speaker Information
Speakers and Panels
Investing and Building the Hub:
The Capital Market Investments and Public-Private Partnerships driving Life-Science Growth and the Development and Renovation Pipeline
Brian Darmody
Chief Strategy Officer
Association of University Research Parks (AURP)
Dr. Anne Khademian
Executive Director
Universities at Shady Grove
Troy LeMaile-Stovall
CEO
TEDCO
Deborah Hemingway
Managing Partner
Ecphora Capital
Prayas Neupane
Director of Economic Development
Montgomery County Economic Development Corporation
Andrew Schwartz
Principal
Stein Sperling
The Life Science Reset:
The Flight to Quality, Tenant Demand, Growing Sectors, and Trends in Design and Fit-Outs affecting Mid-Atlantic Lab and Office Space
Bibhash Mukhopadhyay
CEO
Sapient Biotech
Susan Mitchell
CEO & Founder
Athari BioSciences Inc.
Rupali Lach
Vice President, Commercial Operations
ATCC
Patrick Conley
Senior Scientist
Merrick and Company
Charu McDermott
Senior Project Architect | Vice President
CannonDesign
Colin Regan
Project Manager
The Whiting-Turner Contracting Company
Matthew Brady
President
Scheer Partners
remarks from the podium
David Miller
Chairman of the Board
Miller Paneling Specialties
Who's in the Room
150+ Attendees from:
|
|
|
Why you can't miss this year's Mid-Atlantic Life Science and Biotech Summit
What You'll Learn
How lab vacancy rates are shifting through the glut of oversupply.
Where is bio-manufacturing investment expanding across the Mid-Atlantic.
What tenants require before committing to new life science space.
How capital markets are pricing risk in today's lab real estate.
Where public and private partners are building the region's innovation infrastructure.
Why This Matters
The Mid-Atlantic life science market is entering a new phase, and the picture is more complicated than a simple recovery. Lab vacancy is declining, yet major landlords are still absorbing losses and preparing space vacated by long-time tenants. At the same time, biomanufacturing investment is accelerating, with hundreds of millions of dollars committed to Maryland and Virginia facilities even as traditional leasing stays cautious. Join us as we explore how developers, investors, and innovators are navigating this uneven recovery to keep the Mid-Atlantic among the nation's top life science hubs.
For questions, recommendations, comments, press inquiries, or if you are interested in sponsoring, please email Ian Wheeler at ian.wheeler@bisnow.com. To request disability-related accommodations, please contact janet.fernandez@bisnow.com no later than seven business days prior to the event.
Venue
Bethesda Marriott
5151 Pooks Hill Road
Bethesda, MD 20814
Ballroom: Grand Ballroom
Parking Information:
$12.50/car.
Agenda
| Time | Activity |
|---|---|
|
8:00 AM
9:00 AM
|
Registration, Breakfast, and Networking
|
|
9:00 AM
9:50 AM
|
Investing and Building the Hub:
The Capital Market Investments and Public-Private Partnerships driving Life-Science Growth and the Development and Renovation Pipeline The Mid-Atlantic has long been one of the nation’s leading biopharma clusters, but maintaining that position requires more than adding lab space. Public-private partnerships, universities, research institutions and government agencies are shaping where innovation districts emerge and how infrastructure gets built, while investors and lenders are recalibrating capital around biomanufacturing growth, development opportunities and distressed lab assets. As projects become more specialized and capital remains selective, the economics, complexity and delivery of new and renovated facilities are evolving alongside the market. This panel will examine how capital, public investment and development are converging across the region, what is driving demand for facilities, how projects are getting financed and delivered, and what it will take to build the region’s next generation of life sciences infrastructure. |
|
9:50 AM
10:10 AM
|
Networking Break
|
|
10:10 AM
11:00 AM
|
The Life Science Reset:
The Flight to Quality, Tenant Demand, Growing Sectors, and Trends in Design and Fit-Outs affecting Mid-Atlantic Lab and Office Space Lab vacancy across the Mid-Atlantic has ticked down for the first time in years, largely due to growth in biomanufacturing and other emerging life sciences sectors, creating new sources of demand and changing what tenants need from their facilities. However, the leasing market isn't out of the woods yet. Tenants are consolidating into newer, better-positioned buildings while older lab stock sits empty and landlords rework space built for a tenant that never came. This panel will examine where demand is emerging across the region, what's driving the flight to quality, and how attractive, flexible lab environments, well-designed tenant fit-outs and repositioned assets can help properties compete for the next generation of life sciences tenants. |
|
11:00 AM
12:00 PM
|
Closing Networking
|
PS - Want the attendee list for free?
Biscred gives you a complimentary 1-week trial with 250 credits to search 6M+ commercial real estate contacts — filter by asset class, job seniority, metro, property count, and more. Book a demo today and we'll activate your free trial when you mention this promotion.